Chimeric ScFv Monoclonal Antibody Composed of Tocilizumab-Light Chain, Heavy Chain, and Bacterial Flagellin for the Treatment of Autoimmune Disorder: Insilco Design and Cytotoxicity Study. Journal of Pharmaceutical Negative Results. Published online November 2, 2022:644-659. Accessed June 30, 2026. https://pnrjournal.com/index.php/home/article/view/2794